Profound Medical Corp.
PRN.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -53.04% | -24.77% | -46.88% | -13.45% | 2.20% |
| Total Depreciation and Amortization | -40.17% | -11.67% | -11.37% | -5.25% | 6.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 94.50% | 44.53% | 5.36% | -23.23% | -31.35% |
| Change in Net Operating Assets | -389.85% | -232.98% | 58.91% | -56.25% | -23.05% |
| Cash from Operations | -62.91% | -50.66% | -54.95% | -27.64% | -3.47% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 88.67% | 49.01% | -0.12% | -77.31% | -205.13% |
| Issuance of Common Stock | -31.71% | 70.91% | 70.90% | 69.15% | 2,228.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 79.24% | -63.31% | -63.31% | -63.31% | -- |
| Cash from Financing | -24.79% | 84.37% | 77.51% | 69.17% | 2,888.85% |
| Foreign Exchange rate Adjustments | 183.41% | 111.80% | 157.66% | -167.50% | -577.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -83.24% | 64.67% | 121.48% | 391.19% | 241.35% |